Atazanavir improves cardiometabolic measures but not vascular function in patients with long-standing type 1 diabetes mellitus
about
Atazanavir and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Patients: A Systematic ReviewConflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: A randomized trial of regimen switch to atazanavir.Bilirubin Is Inversely Associated With Cardiovascular Disease Among HIV-Positive and HIV-Negative Individuals in VACS (Veterans Aging Cohort Study).
P2860
Atazanavir improves cardiometabolic measures but not vascular function in patients with long-standing type 1 diabetes mellitus
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Atazanavir improves cardiometa ...... nding type 1 diabetes mellitus
@ast
Atazanavir improves cardiometa ...... nding type 1 diabetes mellitus
@en
type
label
Atazanavir improves cardiometa ...... nding type 1 diabetes mellitus
@ast
Atazanavir improves cardiometa ...... nding type 1 diabetes mellitus
@en
prefLabel
Atazanavir improves cardiometa ...... nding type 1 diabetes mellitus
@ast
Atazanavir improves cardiometa ...... nding type 1 diabetes mellitus
@en
P2093
P2860
P1433
P1476
Atazanavir improves cardiometa ...... nding type 1 diabetes mellitus
@en
P2093
Allison B Goldfine
Caitlin Parmer
Jessica Milian
Jonah P Zuflacht
P2860
P2888
P304
P356
10.1007/S00592-014-0708-6
P577
2015-01-08T00:00:00Z